These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13491414)

  • 61. On migraine headache: serotonin and serotonin antagonism.
    DALESSIO DJ
    JAMA; 1962 Jul; 181():318-21. PubMed ID: 13883200
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of serotonin antagonists on blood platelet aggregation].
    Rysánek K; Svehla C; Spánková H; Mlejnková M
    Act Nerv Super (Praha); 1968 Oct; 10(3):325-6. PubMed ID: 5702550
    [No Abstract]   [Full Text] [Related]  

  • 63. Brom-lysergic acid diethylamide: a highly potent serotonin antagonist.
    SOLLERO L; PAGE IH; SALMOIRAGHI GC
    J Pharmacol Exp Ther; 1956 May; 117(1):10-5. PubMed ID: 13320295
    [No Abstract]   [Full Text] [Related]  

  • 64. Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors.
    Pierce PA; Peroutka SJ
    Neuropsychopharmacology; 1990; 3(5-6):503-8. PubMed ID: 2078283
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotonin, mental state and behavior.
    N Engl J Med; 1967 Nov; 277(21):1146-7. PubMed ID: 6055004
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids.
    CERLETTI A; DOEPFNER W
    J Pharmacol Exp Ther; 1958 Jan; 122(1):124-36. PubMed ID: 13502837
    [No Abstract]   [Full Text] [Related]  

  • 68. Serotonin-sensitive adenylate cyclase in neural tissue and its similarity to the serotonin receptor: a possible site of action of lysergic acid diethylamide.
    Nathanson JA; Greengard P
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):797-801. PubMed ID: 4595572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adenosine cyclic 3',5'-monophosphate in the liver fluke, Fasciola hepatica. I. Activation of adenylate cyclase by 5-hydroxytryptamine.
    Abrahams SL; Northup JK; Mansour TE
    Mol Pharmacol; 1976 Jan; 12(1):49-58. PubMed ID: 176567
    [No Abstract]   [Full Text] [Related]  

  • 70. The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity.
    Banna NR; Anderson EG
    J Pharmacol Exp Ther; 1968 Aug; 162(2):319-25. PubMed ID: 5302116
    [No Abstract]   [Full Text] [Related]  

  • 71. Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.
    Nichols DE; Monte A; Huang X; Marona-Lewicka D
    Behav Brain Res; 1996; 73(1-2):117-9. PubMed ID: 8788487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. d-Lysergic acid diethylamide differentially affects the dual actions of 5-hydroxytryptamine on cortical neurons.
    Pierce PA; Peroutka SJ
    Neuropharmacology; 1990 Aug; 29(8):705-12. PubMed ID: 2148813
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Blockade of 5-hydroxytryptamine antidiuresis in rats by 2-bromlysergic acid diethylamide tartrate and 1-methyl-lysergic acid butanolamide.
    CHODERA A
    J Pharm Pharmacol; 1963 Jun; 15():386-9. PubMed ID: 14020952
    [No Abstract]   [Full Text] [Related]  

  • 75. Mode of action of hallucinogenic molecules.
    Berridge MJ; Prince WT
    Nat New Biol; 1973 Jun; 243(130):283-4. PubMed ID: 4352120
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparative study of acetylcholine and 5-hydroxytryptamine receptors on single snail neurons.
    Stefani E; Gerschenfeld HM
    J Neurophysiol; 1969 Jan; 32(1):64-74. PubMed ID: 4303838
    [No Abstract]   [Full Text] [Related]  

  • 77. Centrally-mediated carcdiovascular responses to 5-HT.
    Lambert G; Friedman E; Gershon S
    Life Sci; 1975 Sep; 17(6):915-9. PubMed ID: 1195987
    [No Abstract]   [Full Text] [Related]  

  • 78. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A; Nicák A
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract]   [Full Text] [Related]  

  • 79. Serotonin antagonists and central hyperthermia produced by biogenic amines in conscious rabbits.
    Girault JM; Jacob JJ
    Eur J Pharmacol; 1979 Jan; 53(2):191-200. PubMed ID: 32059
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Action of biogenic amines on crustacean chromatophores--IV. Analysis of the synergistic erythrophoric pigment dispersion evoked by 5-hydroxytryptamine and lysergic acid diethylamide in the dwarf crayfish, Cambarellus shufeldti.
    Rao KR; Fingerman M
    Comp Biochem Physiol C Comp Pharmacol; 1975 Jun; 51(1):53-8. PubMed ID: 239824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.